Literature DB >> 21838693

Recent developments in protein and cell-targeted aptamer selection and applications.

Jun Liu1, Mingxu You, Ying Pu, Huixia Liu, Mao Ye, Weihong Tan.   

Abstract

Because of their easily modified chemical structures and wide range of targets, aptamers are ideal candidates for various applications, such as biomarker discovery, target diagnosis, molecular imaging, and drug delivery. Aptamers are oligonucleotide sequences that can bind to their targets specifically via unique three dimensional (3-D) structures. Usually, aptamers are obtained from repeated rounds of in vitro or in vivo selection termed SELEX (Systematic Evolution of Ligands by EXponential enrichment), which can generate aptamers with high affinity and specificity for many kinds of targets, such as biomedically important proteins and even cancer cells. In this review, some basic principles and recent developments in the design of SELEX process are discussed, hopefully to provide some guidelines towards performing more efficient aptamer isolation procedures. Moreover, the biomedical and bioanalytical applications of aptamers are further reviewed, based on some smart biochemical modifications of these oligonucleotide structures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838693      PMCID: PMC5512708          DOI: 10.2174/092986711797189619

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  98 in total

Review 1.  The application of mass spectrometry to membrane proteomics.

Authors:  Christine C Wu; John R Yates
Journal:  Nat Biotechnol       Date:  2003-03       Impact factor: 54.908

2.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.

Authors:  J Colin Cox; Andrew Hayhurst; Jay Hesselberth; Travis S Bayer; George Georgiou; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 4.  Gene therapy progress and prospects: RNA aptamers.

Authors:  N S Que-Gewirth; B A Sullenger
Journal:  Gene Ther       Date:  2007-02       Impact factor: 5.250

Review 5.  Methods developed for SELEX.

Authors:  Subash Chandra Bose Gopinath
Journal:  Anal Bioanal Chem       Date:  2006-10-28       Impact factor: 4.142

6.  Selection of aptamers against live bacterial cells.

Authors:  Camille L A Hamula; Hongquan Zhang; Le Luo Guan; Xing-Fang Li; X Chris Le
Journal:  Anal Chem       Date:  2008-09-20       Impact factor: 6.986

7.  Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

Authors:  Lee Adam Wheeler; Radiana Trifonova; Vladimir Vrbanac; Emre Basar; Shannon McKernan; Zhan Xu; Edward Seung; Maud Deruaz; Tim Dudek; Jon Ivar Einarsson; Linda Yang; Todd M Allen; Andrew D Luster; Andrew M Tager; Derek M Dykxhoorn; Judy Lieberman
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

Review 8.  Using aptamers to visualize and capture cancer cells.

Authors:  Ying Pu; Zhi Zhu; Huixia Liu; Jiani Zhang; Jun Liu; Weihong Tan
Journal:  Anal Bioanal Chem       Date:  2010-05-18       Impact factor: 4.142

9.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

10.  One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX.

Authors:  Andreas Nitsche; Andreas Kurth; Anna Dunkhorst; Oliver Pänke; Hendrik Sielaff; Wolfgang Junge; Doreen Muth; Frieder Scheller; Walter Stöcklein; Claudia Dahmen; Georg Pauli; Andreas Kage
Journal:  BMC Biotechnol       Date:  2007-08-15       Impact factor: 2.563

View more
  14 in total

1.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

Review 2.  Applications of aptamers in targeted imaging: state of the art.

Authors:  Casey A Dougherty; Weibo Cai; Hao Hong
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.

Authors:  Nianxi Zhao; Sung-nan Pei; Parag Parekh; Eric Salazar; Youli Zu
Journal:  Int J Biochem Cell Biol       Date:  2014-03-22       Impact factor: 5.085

4.  Selection of aptamers for mature white adipocytes by cell SELEX using flow cytometry.

Authors:  Eun Young Kim; Ji Won Kim; Won Kon Kim; Baek Soo Han; Sung Goo Park; Bong Hyun Chung; Sang Chul Lee; Kwang-Hee Bae
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

5.  Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.

Authors:  Ka-To Shum; Jiehua Zhou; John J Rossi
Journal:  J Cancer Ther       Date:  2013-06-01

6.  Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX.

Authors:  Guodong Wang; Jun Liu; Ke Chen; Yiling Xu; Bo Liu; Jie Liao; Lei Zhu; Xiaoxiao Hu; Jianglin Li; Ying Pu; Wen Zhong; Ting Fu; Huixia Liu; Weihong Tan
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

7.  Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.

Authors:  Yacong An; Yan Hu; Xundou Li; Zhaoyi Li; Jinhong Duan; Xian-Da Yang
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

8.  ProtSeq: Toward high-throughput, single-molecule protein sequencing via amino acid conversion into DNA barcodes.

Authors:  Jessica M Hong; Michael Gibbons; Ali Bashir; Diana Wu; Shirley Shao; Zachary Cutts; Mariya Chavarha; Ye Chen; Lauren Schiff; Mikelle Foster; Victoria A Church; Llyke Ching; Sara Ahadi; Anna Hieu-Thao Le; Alexander Tran; Michelle Dimon; Marc Coram; Brian Williams; Phillip Jess; Marc Berndl; Annalisa Pawlosky
Journal:  iScience       Date:  2021-12-11

9.  Aptamer-based therapeutics: new approaches to combat human viral diseases.

Authors:  Ka-To Shum; Jiehua Zhou; John J Rossi
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-25

10.  The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity.

Authors:  Xu Wang; Yi Yang; Mingyue Jia; Chi Ma; Mingyu Wang; Lihe Che; Yu Yang; Jiang Wu
Journal:  Neural Regen Res       Date:  2013-01-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.